Jaguar Gene Therapy
<UNKNOWN> · 4 known investors
Jaguar Gene Therapy develops gene therapy treatments for severe genetic diseases, focusing on AAV-based platform therapies designed to deliver one-time, long-lasting treatments. The company serves patients with severe genetic diseases with significant unmet medical needs.
Investors · 4
In the news
- Jaguar Gene Therapy completes Cohort I patient dosing in JAG201 clinical trialclinicaltrialsarena.com · 2026
- Samsung invests in Chicago biotech Jaguar Gene Therapy - Chicago Business Journalbizjournals.com · 2022
- News | Jaguar Gene Therapyjaguargenetherapy.com · 2021
- Jaguar Gene Therapy Closes $139 Million Series B Funding Co-led by Eli Lilly and Company and Deerfield Management - BioSpacebiospace.com · 2021
- Jaguar Gene Therapy Closes $139 Million Series B Funding Co-led by Eli Lilly and Company and Deerfield Management | Jaguar Gene Therapyjaguargenetherapy.com · 2021